FI883455A7 - Leukotrienantagonister, foerfaranden foer deras framstaellning, deras anvaendning vid behandling av sjukdomar samt foerprodukter. - Google Patents
Leukotrienantagonister, foerfaranden foer deras framstaellning, deras anvaendning vid behandling av sjukdomar samt foerprodukter. Download PDFInfo
- Publication number
- FI883455A7 FI883455A7 FI883455A FI883455A FI883455A7 FI 883455 A7 FI883455 A7 FI 883455A7 FI 883455 A FI883455 A FI 883455A FI 883455 A FI883455 A FI 883455A FI 883455 A7 FI883455 A7 FI 883455A7
- Authority
- FI
- Finland
- Prior art keywords
- deras
- leukotrienantagonister
- foerprodukter
- sjukdomar
- samt
- Prior art date
Links
- 101100148710 Clarkia breweri SAMT gene Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/14—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873724735 DE3724735A1 (de) | 1987-07-25 | 1987-07-25 | Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten, sowie vorprodukte |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI883455A0 FI883455A0 (fi) | 1988-07-21 |
| FI883455A7 true FI883455A7 (fi) | 1989-01-26 |
Family
ID=6332390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI883455A FI883455A7 (fi) | 1987-07-25 | 1988-07-21 | Leukotrienantagonister, foerfaranden foer deras framstaellning, deras anvaendning vid behandling av sjukdomar samt foerprodukter. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4851440A (cs) |
| EP (1) | EP0301401B1 (cs) |
| JP (1) | JPS6447759A (cs) |
| KR (1) | KR890001974A (cs) |
| AT (1) | ATE69809T1 (cs) |
| AU (1) | AU610201B2 (cs) |
| DE (2) | DE3724735A1 (cs) |
| DK (1) | DK412388A (cs) |
| ES (1) | ES2040783T3 (cs) |
| FI (1) | FI883455A7 (cs) |
| GR (1) | GR3003525T3 (cs) |
| IL (1) | IL87197A0 (cs) |
| NO (1) | NO167799C (cs) |
| NZ (1) | NZ225518A (cs) |
| PT (1) | PT88074B (cs) |
| ZA (1) | ZA885335B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5286895A (en) * | 1992-02-19 | 1994-02-15 | Merck & Co., Inc. | Cholesterol lowering compounds |
| KR100411191B1 (ko) * | 1996-06-12 | 2004-03-30 | 한솔제지주식회사 | 재활용이 용이한 방습지 |
| WO2012157760A1 (ja) * | 2011-05-19 | 2012-11-22 | 宇部興産株式会社 | 多価ビニル芳香族化合物およびその製造方法 |
| US12037327B2 (en) * | 2018-05-04 | 2024-07-16 | Saint Louis University | Compounds and methods targeting GPER for treatment of diseases associated with calcium |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3867434A (en) * | 1971-11-04 | 1975-02-18 | Rorer Inc William H | Phenyl butyric acids and derivatives thereof |
| US3894080A (en) * | 1970-05-05 | 1975-07-08 | Rorer Inc William H | Phenylacetic acids |
| AT336589B (de) * | 1974-05-20 | 1977-05-10 | Thomae Gmbh Dr K | Verfahren zur herstellung von neuen biphenylderivaten |
| US4513005A (en) * | 1981-06-18 | 1985-04-23 | Lilly Industries Limited | SRS-A antagonists |
| US4785004A (en) * | 1985-12-23 | 1988-11-15 | Ciba-Geigy Corporation | Aromatic thioethers |
| GB2190377A (en) * | 1986-05-14 | 1987-11-18 | Merck Frosst Canada Inc | Phenyldithiaalkanedioic acids as leukotriene antagonists |
-
1987
- 1987-07-25 DE DE19873724735 patent/DE3724735A1/de not_active Withdrawn
-
1988
- 1988-07-21 FI FI883455A patent/FI883455A7/fi not_active Application Discontinuation
- 1988-07-21 EP EP88111746A patent/EP0301401B1/de not_active Expired - Lifetime
- 1988-07-21 DE DE8888111746T patent/DE3866460D1/de not_active Expired - Fee Related
- 1988-07-21 ES ES198888111746T patent/ES2040783T3/es not_active Expired - Lifetime
- 1988-07-21 AT AT88111746T patent/ATE69809T1/de not_active IP Right Cessation
- 1988-07-22 ZA ZA885335A patent/ZA885335B/xx unknown
- 1988-07-22 PT PT88074A patent/PT88074B/pt not_active IP Right Cessation
- 1988-07-22 NO NO883286A patent/NO167799C/no unknown
- 1988-07-22 JP JP63181945A patent/JPS6447759A/ja active Pending
- 1988-07-22 NZ NZ225518A patent/NZ225518A/xx unknown
- 1988-07-22 AU AU19296/88A patent/AU610201B2/en not_active Ceased
- 1988-07-22 US US07/222,975 patent/US4851440A/en not_active Expired - Fee Related
- 1988-07-22 IL IL87197A patent/IL87197A0/xx unknown
- 1988-07-22 DK DK412388A patent/DK412388A/da not_active Application Discontinuation
- 1988-07-23 KR KR1019880009266A patent/KR890001974A/ko not_active Withdrawn
-
1992
- 1992-01-08 GR GR910402037T patent/GR3003525T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU610201B2 (en) | 1991-05-16 |
| NZ225518A (en) | 1990-08-28 |
| NO883286D0 (no) | 1988-07-22 |
| NO167799C (no) | 1991-12-11 |
| NO167799B (no) | 1991-09-02 |
| EP0301401A2 (de) | 1989-02-01 |
| DK412388D0 (da) | 1988-07-22 |
| NO883286L (no) | 1989-01-26 |
| PT88074A (pt) | 1989-06-30 |
| US4851440A (en) | 1989-07-25 |
| IL87197A0 (en) | 1988-12-30 |
| GR3003525T3 (cs) | 1993-03-16 |
| ES2040783T3 (es) | 1993-11-01 |
| EP0301401B1 (de) | 1991-11-27 |
| KR890001974A (ko) | 1989-04-07 |
| ZA885335B (en) | 1989-03-29 |
| AU1929688A (en) | 1989-01-27 |
| EP0301401A3 (en) | 1989-05-10 |
| DE3866460D1 (de) | 1992-01-09 |
| JPS6447759A (en) | 1989-02-22 |
| DK412388A (da) | 1989-01-26 |
| PT88074B (pt) | 1995-03-01 |
| ATE69809T1 (de) | 1991-12-15 |
| DE3724735A1 (de) | 1989-02-02 |
| FI883455A0 (fi) | 1988-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI885819L (fi) | Giftfria aryloniumsalter, i uv-ljus vulkaniserbara belaeggningskompositioner samt deras anvaendning vid foerpackning av matvaror. | |
| FI875714L (fi) | Foerfarande foer verifiering av namnteckning samt anordning foer utfoerande av foerfarandet. | |
| FI872015A7 (fi) | Foerfarande foer framstaellning av farmaceutiskt anvaendbara styrylpyrazoler och -isoxazoler samt deras analoger. | |
| FI880279L (fi) | Foerfarande foer framstaellning av avermektiner samt vid detta foerfarande anvaendbara bakteriekulturer. | |
| FI901050A0 (fi) | Foerfarande foer generering av en oxiderande flamma, en braennare samt en anvaendning foer en braennare. | |
| FI871164A0 (fi) | Foerfarande foer framstaellning av en haerdad stenmaterialprodukt, isynnerhet betong, samt anordning avsedd foer anvaendning vid foerfarandet. | |
| FI871699A7 (fi) | 1-hydroxi-2-pyridoner, foerfarande foer deras framstaellning och dessa innehaollande laekemedel samt vid framstaellning av 1-hydroxi-2-pyridoner bildade mellanprodukter. | |
| FI883371A7 (fi) | Foerfarande foer behandling av brandrester vid en foerbraenningsanlaeggning, saerskilt vid en sopfoerbraenningsanlaeggning. | |
| FI872758L (fi) | Foerfarande foer framstaellning av oligoestrar, vilka innehaoller hydroxylgrupper, samt deras anvaendning. | |
| FI885399L (fi) | Ny medicinsalva, foerfarande foer dess framstaellning, vid anvaendning av denna medicinsalva framstaellda applikationsformer samt framstaellning av dessa. | |
| FI882855A7 (fi) | Foerfarande foer framstaellning av aemnen av elastiskt papper, foeretraedesvis av kraeppat papper, samt anordning foer genomfoerande av foerfarandet. | |
| FI870768A7 (fi) | Fotopolymeriserbar blandning, denna innehaollande ljuskaensligt registreringselement samt foerfarande foer framstaellning av en plantrycksform medelst detta ljuskaensliga registreringselement. | |
| FI870285L (fi) | Foerfarande foer placering av skivformiga foeremaol samt anordning foer detta. | |
| FI863396L (fi) | Foerfarande foer utfoering av en gjutning pao en profilskiva samt en profilskiva, daer foerfarandet tillaempats. | |
| FI843959A0 (fi) | Nytt foerfarande foer framstaellning av kefalosporiner, vid framstaellning av kefalosporin anvaendbar mellanprodukt samt foerfarande foer framstaellning av naemnda mellanprodukt. | |
| FI903763A0 (fi) | 14-17a-eteno och -etanoestratriener, foerfarande foer framstaellning av dessa foereningar samt anvaendning av dessa vid framstaellning av laekemedel. | |
| FI884200A7 (fi) | Foerfarande foer vid framstaellning av ace-inhibitorer anvaendbara fosfinsyror samt vid framstaellningen framstaellbara mellanprodukter. | |
| FI891210L (fi) | Tiosulfinsyraderivat, deras anvaendning vid inflammationssjukdomar samt laekemedel innehaollande dessa aemnen. | |
| FI875196L (fi) | Foerfarande foer formering av en fiberbana i en pappersmaskin samt en anordning foer utfoering av foerfarandet. | |
| FI883472L (fi) | Foerfarande foer reducering av volymen av avfall samt anordning foer utfoerande av foerfarandet. | |
| FI885797A0 (fi) | Peptider, foerfarande foer deras framstaellning, deras anvaendning vid framstaellning av antikroppar samt anvaendning av dessa foer blockering av pai-1-aktiviteten av maenniskans blod. | |
| FI875787A0 (fi) | Foerfarande foer framstaellning av lipofila aminosyraderivat, samt lipofila aminosyraderivat. | |
| FI883455A7 (fi) | Leukotrienantagonister, foerfaranden foer deras framstaellning, deras anvaendning vid behandling av sjukdomar samt foerprodukter. | |
| FI881085L (fi) | I vatten svaellande, tvaerbundna polymerer samt foerfarande foer deras framstaellning. | |
| FI875765A0 (fi) | Foerfarande foer drivande av en foerbraenningsanlaeggning samt en anlaeggning foer genomfoerande av foerfarandet. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn [patent] |
Owner name: HOECHST AKTIENGESELLSCHAFT |